Dignitana

Dignitana AB, scalp cooling innovation leader­, will present the advanced technology of the DigniCap Delta Scalp Cooling System at Onkologidagarna held March 19 - 21 in Malmö Sweden.

With a theme of "Oncology of the future - in Sweden and in the world," the event brings together oncology nurses and palliative medicine clinicians from across Sweden to exchange information and experience between clinical professionals and industry leaders.

"As we continue to grow the business and expand our global presence, we appreciate this opportunity to showcase the state-of the-art technology in DigniCap Delta to the oncology community in our home market of Sweden. Scalp cooling is an important quality of life improvement for cancer patients, and the investments we are making now support our ongoing commitment to superior clinical outcomes and progress to increase patient access to this treatment ,"  said Catarina Löwenadler, CEO of Dignitana.

Scalp cooling to minimize hair loss from chemotherapy is listed as a treatment recommendation in the clinical practice guidelines published by European Society for Medical Oncology (ESMO), National Comprehensive Cancer Network® (NCCN) and Cancer Australia.